Sustainable Pharmaceutical Packaging Market Size Worth $315.59 Billion by 2032 | CAGR: 16.15%

Sustainable Pharmaceutical Packaging Market Size Worth $315.59 Billion by 2032 | CAGR: 16.15%

The global sustainable pharmaceutical packaging market size is expected to reach USD 315.59 billion by 2032, according to a new study by Polaris Market Research. The report Sustainable Pharmaceutical Packaging Market Size, Share & Trends Analysis Report by Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2032 gives a detailed insight into current market dynamics and provides analysis on future market growth.

The enormous growth of the pharmaceutical business is one of the primary forces behind the development of the Sustainable Pharmaceutical Packaging sector. The pharmaceutical industry has experienced rapid growth in recent years due to scientific and technological developments, and it is anticipated that this pattern will continue over the course of the projection period, particularly in developing nations like China, India, and Brazil. The United States had the largest pharmaceutical market in the globe.

The size of the healthcare system, the high per capita income, and the sizeable expenditures made in drug research in the country are some of the key factors affecting the U.S. market. Furthermore, due to the growing importance of generic medications and the accessibility of improved healthcare services, lucrative opportunities for Sustainable Pharmaceutical Packaging are expected in the upcoming years. On December 13, 2016, President Obama signed the 21st Century Cures Act (Cures Act), which seeks to speed up the development of medical products.

The pharmaceutical industry is mainly driven by advances in biomedicine and science. In addition, as one of the most prosperous high-tech sectors on the continent, the pharmaceutical industry makes a substantial economic contribution to Europe. The pharmaceutical industry is experiencing a significant transformation, and over the past few years, the development of biopharmaceutical drugs has drawn increasingly more attention. Due to their instability in liquid form, few biotechnology-based drug treatments are introduced as lyophilized or dry powder dosage forms.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:

The Covid-19 pandemic was advantageous for the industry. Investments in drug discovery as well as greater production and consumption of pharmaceuticals allowed for a rise in the demand for packing. Concern over the virus's ability to live on packing surfaces was another issue brought on by the disease outbreak, which increased the production of high-performance and environmentally friendly packaging.

Businesses are mainly focusing on using post-consumer recycled (PCR) material and making packaging from compostable material to improve the sustainability of packaging. Gerresheimer AG, a market leader in sustainable pharmaceutical packaging, has been offering glass boxes constructed of PCR glass for some time.

Sustainable Pharmaceutical Packaging Market Report Highlights

  • Plastics & polymers, with a 36.9% income share, was the industry with the highest income share in 2022. Numerous plastic resins, including PE, PET, PP, PVC, PS, and bioplastic, are commonly used to make pharmaceutical containers, bottles, closures, needles, pouches, sachets, cartridges, tubes, and blister packs.
  • The main category controlled the largest share of the market in 2022. Primary packaging, which encloses and comes into direct contact with the medicine to protect it from contamination, includes bottles, tubes, and blister packs. It frequently deals with the dosing and administration of medication components.
  • From 2023 to 2032, it is anticipated that the crucial end-use industry of pharmaceutical manufacturing, which accounted for the largest share of 49.9% in 2022, will grow quickly. This is due to people's increased demand for medications. The World Health Organization (WHO) predicts that between 2015 and 2050, the proportion of individuals over 60 in the global population will nearly double, rising from 12% to 22%.
  • North America led the market in 2022 with a revenue share of 35.9%. Pharmaceutical manufacturing, which includes in-house production, was the biggest end-use industry in the region.
  • The global players include Amcor Plc, Aptargroup, Inc., Becton, Dickinson and Company, Berry Global Inc., Catalent, Inc., CCL Industries, Inc., Comar, LLC, Drug Plastics Group, Gerresheimer AG, International Paper, Nipro Corporation, Owens Illinois Inc., Schott AG, Silgan Holdings Inc.

Polaris Market Research has segmented the Sustainable Pharmaceutical Packaging Market report based on product type, process and region:

Sustainable Pharmaceutical Packaging, Material Outlook (Revenue - USD Billion, 2019 - 2032)

  • Plastic and Polymer
  • Paper and Paper Board
  • Glass
  • Aluminium Foil
  • Others

Sustainable Pharmaceutical Packaging, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Primary
  • Secondary
  • Tertiary

Sustainable Pharmaceutical Packaging, End-use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pharma Manufacturing
  • Contract Packaging
  • Retail Pharmacy
  • Institutional Pharmacy

Sustainable Pharmaceutical Packaging, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa